Side Effects of Targeted Therapy

Targeted therapy is a cornerstone of precision medicine. It involves using medication that recognises and interferes with abnormal proteins and genetic changes found in cancer cells, stopping them from growing while leaving most healthy cells alone (1). Like other forms of cancer treatment, there are many side effects associated with targeted therapy. These depend on the type of targeted therapy you are on, your dosage, your cancer type, among other things. This article highlights the most common side effects of targeted therapy and explains why they occur, how to manage them, and when it's appropriate to speak with your healthcare team. 

AI generated image of female cancer patient arranging a vase of flowers at the kitchen table.

How does Targeted Therapy Cause Side Effects?

Targeted therapy destroys cancer cells by interfering with cancer-specific genes and proteins. Because healthy cells can sometimes have these proteins and express similar genes, they get destroyed during targeted therapy as well, which is why side effects show up (2).

Normal cells likely to be affected by targeted therapy include cells in your: 

  • Hair
  • Skin
  • Nails
  • Liver
  • Eye

What Are the Most Common Side Effects of Targeted Cancer Therapy?

The most common side effects of cancer therapy include hair changes, skin changes, nail changes, eye changes, among others. Side effects of targeted therapy can vary depending on the type of therapy you're receiving. Some side effects happen more often than others, and some can be more serious than others. You should talk to your medical team about what to pay attention to or how to take care of them yourself. Here is more information about the more common side effects:

Hair Changes Due to Targeted Therapy

Common hair changes associated with targeted therapy for cancer include: sores in places where hair grows, or notice changes in the structure or colour of your hair. Targeted therapy can cause hair loss. Hair changes as a result of targeted therapy typically develop over time. This doesn't mean that you are allergic to the drug (2).

Skin Changes Due to Targeted Therapy

When drugs like EGFR inhibitors attack the special proteins associated with some healthy cells, it can produce skin irritations, dry and brittle skin, and rashes. You may be prescribed products to ease these symptoms. But speak to your doctor first (4).

Nail Changes

Some common nail changes associated with targeted therapy include swollen, red, painful sores around fingernails and toenails, which can lead to infected nails or nailbeds (5).

Eye Changes from Targeted Therapy

Eye changes as a result of targeted therapy include:

  • Dryness
  • Redness
  • Swelling
  • Eyelids turning inward or outward
  • Eyelashes growing longer
  • Distorted eyelids, or
  • Damage to the cornea (6)

It's recommended that you speak to your doctor about these changes and get proper management.

Allergic or Infusion Reaction Caused by Targeted Therapy

This might start very soon after you've taken targeted therapy drugs. Some symptoms to watch out for are hives and intense itching (7). Other more serious symptoms can include:

  • Difficulty breathing
  • Dizziness
  • Tightness in your throat or chest, and
  • Swelling of your lips or your tongue.

If you experience more severe symptoms, you should get emergency care right away.

Blood Pressure

Targeted cancer therapy can cause higher blood pressure. Common drugs that do so include BTK inhibitors, proteasome inhibitors, and MEK inhibitors, among others (8). If your blood pressure spikes during treatment with targeted therapy, you may be prescribed special medicines to help reduce blood pressure.

Bleeding and Clotting Due to Targeted Therapy

While bleeding and clotting as a result of cancer therapy are very rare, cancer therapy can cause bruising, bleeding and clotting. Blood clots can form in your lungs or legs. Also, blood clots can cause heart attacks or strokes (9). Immediately alert your doctor if you experience any symptoms like: 

  • Chest pain
  • Shortness of breath
  • Vision problems
  • Trouble speaking
  • Vomiting
  • Blood in your stool
  • Swollen, painful, and red skin on one or both legs or calves

Slow Wound Healing

Some targeted therapy drugs can interfere with how your body heals wounds. Sometimes wounds may open inside your body or on the outside. If you experience any stomach pain or vomiting, you should tell your doctor (10). If you have surgery planned, tell your healthcare team. Some targeted therapies may need to be paused before and after surgery to allow proper wound healing.

Heart Damage

Symptoms of heart damage can occur as a result of targeted therapy (11). These include:

  • Chest pain
  • Weakness
  • Dizziness
  • Increased coughing
  • Trouble breathing

Autoimmune Reaction after Targeted Therapy

Some targeted therapies can affect immune function, but widespread autoimmune side effects are more commonly associated with certain types of immunotherapy. The risk depends on the medicine being used (12).

Swelling and Targeted Therapy

Swelling can also be a side effect of targeted therapy and is usually experienced on the face, around the eyes, and in the feet and legs as well (13).

DID YOU KNOW?

Targeted cancer therapy may also affect some normal cells. Let your care team know if you experience any unusual side effects.

Can Targeted Therapy cause Long-Term Side Effects?

It can, but side effects of targeted therapy usually last for a few weeks to a few months. Even though the side effects tend to stop when the treatment ends, it is possible for long-term side effects to persist. They can persist throughout the treatment, or just show up after the treatment has been concluded. 

Long-term side effects show up because certain targeted therapy drugs impact organs for a while after they have been discontinued. You should discuss any long-term side effects with your healthcare team. 

Managing Side Effects and Knowing when to Seek Help

Some people experience side effects, and others don’t. If you have side effects, you may have them worse or better than other people. Your supervising medical professional team will explain which side effects are most common with your treatment and how to manage them. They can offer you prescription drugs that would help, provide lifestyle tips and modifications that can help you. You must speak to your team. Tell them about: 

  • Your side effects
  • How long they have lasted
  • How frequent they are
  • How severe they are

When Should you Contact your Medical Team? 

Because side effects can sometimes be life-threatening, it is important for you to mention them to your care team. You should report any new or worsening side effects. Most side effects are easier to manage when reported early. In some cases, your medical team may decide to change the dosage of your drugs and provide you with other options to ease your side effects. 

Targeted Therapy versus Chemotherapy

Targeted therapy typically causes fewer side effects than chemotherapy because, unlike chemotherapy, which destroys any cells that fit the ‘cancer’ description, both healthy cells and cancerous ones, targeted therapy only targets cells that show changes suggestive of cancer. As a result, targeted therapy produces much fewer and less severe side effects than chemotherapy but certain targeted therapies are associated with severe, long-term toxicities.  

Key Takeaways

Targeted therapy is a form of cancer treatment that works by interfering with specific genetic or molecular changes that help cancer cells grow and survive. As such, the side effects of targeted therapy are often not very profound but are still a concern. They can vary in intensity from person to person. Some are severe enough to be considered emergencies. Report any side effects to your care team. 

References:

  1. [1] Bindiganavile SH, et al. Targeted cancer therapy and its ophthalmic side effects: a review. J Immunother Precis Oncol. 2021;4(1):6–15. doi:10.36401/JIPO-20-21
  2. [2] Smith CEP, et al. Targeted Cancer Therapies. Am Fam Physician. 2021 Feb 1;103(3):155-163. PMID: 33507053.
  3. [3] Altinbas, M. et al.  Journal of Cancer Research and Therapeutics, 16(3), 690–692. https://doi.org/10.4103/jcrt.JCRT_343_17
  4. [4] Apalla Z,  et. al. Management of human epidermal growth factor receptor inhibitors-related acneiform rash: A position paper based on the first Europe/USA Delphi consensus process. J Eur Acad Dermatol Venereol.  2025; 39: 730–741. https://doi.org/10.1111/jdv.20391
  5. [5] Liu TH, et al. Effective and enduring surgical treatment for targeted therapy-related paronychia: A retrospective study. Medicine (Baltimore). 2022 Oct 21;101(42):e31208. doi: 10.1097/MD.0000000000031208. PMID: 36281135; PMCID: PMC9592431.
  6. [6] Bindiganavile SH, et al. Targeted Cancer Therapy and Its Ophthalmic Side Effects: A Review. J Immunother Precis Oncol. 2021 Feb 25;4(1):6-15. doi: 10.36401/JIPO-20-21. PMID: 35664825; PMCID: PMC9161666.
  7. [7] Barroso A, Estevinho F, Hespanhol V, Teixeira E, Ramalho-Carvalho J, Araújo A. Management of infusion-related reactions in cancer therapy: strategies and challenges. ESMO Open. 2024 Mar;9(3):102922. doi: 10.1016/j.esmoop.2024.102922. Epub 2024 Mar 6. PMID: 38452439; PMCID: PMC10937241. 
  8. [8] Chen, S.T, et al. Hypertension and incident cardiovascular events after next-generation BTKi therapy initiation. J Hematol Oncol 15, 92 (2022). https://doi.org/10.1186/s13045-022-01302-7
  9. [9] Watson, N. and Al-Samkari, H. (2021), Thrombotic and bleeding risk of angiogenesis inhibitors in patients with and without malignancy. J. Thromb. Haemost., 19: 1852-1863. https://doi.org/10.1111/jth.15354
  10. [10] Murphy AD, et al. The role of vascular endothelial growth factor inhibitors in the treatment of epithelial ovarian cancer. Br J Cancer. 2022 Apr;126(6):851-864. doi: 10.1038/s41416-021-01605-5. Epub 2021 Oct 29. PMID: 34716396; PMCID: PMC8927157.
  11. [11] Ekram J, et al. Unveiling the cardiotoxicity conundrum: Navigating the seas of tyrosine kinase inhibitor therapies. Cancer Control. 2024;31:10732748241285755. doi:10.1177/10732748241285755
  12. [12] Sun Y, et al. Autoimmune-related adverse events induced by immune checkpoint inhibitors. Curr Opin Immunol. 2025 Jun;94:102556. doi: 10.1016/j.coi.2025.102556. Epub 2025 Apr 11. PMID: 40220485.
  13. [13] Lin JX, et al. Comprehensive management of MET tyrosine kinase inhibitor-induced peripheral edema in patients with MET-altered non-small-cell lung cancer: a narrative review. Transl Lung Cancer Res. 2025;14(4). doi:10.21037/tlcr-24-866

Disclaimer

This information is provided for educational purposes only. It is general in nature and is not intended to replace professional medical advice, diagnosis, or treatment. Always consult your healthcare team regarding any questions or concerns about your health or care.

  • Cancer
  • Side Effects
  • Cancer Care

Related Pages